HUS-yhtymae

Address
Stenbackinkatu 9

Sponsor Overview

assignment
34
sponsored trials
science
62
molecules
location_city
47
research centres
public
4
countries
person_search
130
investigators

Specializations

Oncology and Hematologic Malignancies

HUS-yhtymae supports clinical research in breast cancer, colorectal cancer, rectal cancer, gastric cancer, pancreatic cancer, head and neck carcinoma, and broader advanced cancer care, with additional interest in myeloma multiplex and Monoclonal Gammopathy of Renal Significance.

  • Targeted anti-cancer therapies
  • Neoadjuvant and adjuvant cancer treatment
  • Minimal residual disease assessment
  • Early access to oncology medicines

Its oncology portfolio also includes treatment-related thromboprophylaxis, perioperative support, and evaluation of antineoplastic therapies across solid tumours and plasma cell disorders.

Neurology, Neurosurgery, and Sleep-Related Disorders

The sponsor funds studies in chronic subdural hematoma, delirium, acute neurological disease, neurodegenerative disease, neuropathic pain, and infantile spasm syndrome, alongside research on cerebral physiology and brain function.

  • Brain circulation and cerebrospinal fluid dynamics
  • Anticoagulation in neurosurgical patients
  • Sleep structure in pain disorders
  • Prevention of early-life epileptic syndromes

Research activity also extends to neurological outcomes linked with consciousness states, sedation, and recovery in complex brain-related conditions.

Surgery, Perioperative Care, and Transplantation

Clinical studies cover acute cholecystitis, hysterectomy, kidney transplantation, venous thromboembolism in surgical patients, and perioperative management in scoliosis surgery and other operative settings.

  • Infection prevention around surgery
  • Blood management and transfusion reduction
  • Graft function in transplantation
  • Thrombosis prevention in surgical care

Its surgical research also includes frostbite injury management and postoperative outcome optimisation across general, abdominal, gynecologic, and urologic procedures.

Ophthalmology, Endocrinology, and Reproductive Health

HUS-yhtymae is active in glaucoma research, polycystic ovary syndrome, and women’s health studies related to operative and metabolic care.

  • Glaucoma treatment strategies
  • Metabolic treatment in polycystic ovary syndrome
  • Perioperative care in gynecologic surgery
  • Hormonal and reproductive medicine

These studies reflect interest in both chronic outpatient management and procedure-related outcomes in endocrine and reproductive conditions.

Infectious Disease, Immunology, and Rare Benign Tumours

The sponsor also funds research in Clostridioides difficile, acute laryngitis, laryngeal leukoplakia, and Warthin's tumor, together with vaccine-related immune response studies and antimicrobial evaluation.

  • Antimicrobial and prophylactic treatment
  • Vaccine immunogenicity
  • Benign head and neck tumour care
  • Upper airway inflammatory conditions

Additional interest is seen in healthy volunteers and healthy adults for translational studies supporting safety and immune response assessment.

Sponsored Trials

Trial Name Country Status
A Randomized Controlled Trial Evaluating Metformin and Metformin Hydrochloride Dosing in Overweight Adults with Polycystic Ovary SyndromeFinland FinlandNot Yet Recruiting
A Randomized, Placebo-Controlled Study on Prophylactic Azithromycin and Cefuroxime Versus Cefuroxime Alone for Post-Hysterectomy Infection PreventionFinland FinlandRecruiting
Apixaban for Venous Thromboembolism Prophylaxis During Neoadjuvant Therapy in Muscle‑Invasive Bladder Cancer: International Randomized Controlled TrialFinland FinlandNot Yet Recruiting
Comparative Efficacy of Selective Laser Trabeculoplasty Versus Tafluprost in Primary Treatment of Exfoliation Ocular Hypertension or GlaucomaFinland FinlandNot Yet Recruiting
Comparison of OctaplasLG and Plasma-Lyte 148 in Fluid Management for Pediatric Instrumented Spinal Fusion in Neuromuscular and Adolescent Idiopathic ScoliosisFinland FinlandRecruiting
Early Access Study of Zongertinib for the Treatment of Cancer in Patients Eligible for Anticancer TherapyFinland FinlandRecruiting
Efficacy of Oral Prednisolone Versus Placebo in the Management of Acute Laryngitis in Vocal Professionals: A Randomized Controlled TrialFinland FinlandRecruiting
Esketamine Interaction Study in Healthy Volunteers: A Clinical Trial EvaluationFinland FinlandNot Recruiting
Evaluation of Accelerator-Based Boron Neutron Capture Therapy in Patients with Head and Neck CarcinomaFinland FinlandNot Recruiting
Evaluation of Apixaban Versus No Anticoagulation for Thromboprophylaxis in Patients Undergoing Abdominal, Gynecologic, and Urologic SurgeryFinland FinlandRecruiting
1–10 of 34
1 / 4

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 62 total (0% not shared with other sponsors)

This sponsor works with 62 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
34%
Return partnership rate
16 of 47 sites collaborated multiple times

This sponsor has worked with 47 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Neoplasms10 trials
    879 other sponsors
  • 2.
    Nervous System Diseases4 trials
    464 other sponsors
  • 3.
    Therapeutics4 trials
    90 other sponsors
  • 4.
    Otorhinolaryngologic Diseases3 trials
    53 other sponsors
  • 5.
    Hemic and Lymphatic Diseases2 trials
    258 other sponsors
  • 6.
    Metabolism2 trials
    39 other sponsors
  • 7.
    Musculoskeletal Diseases2 trials
    246 other sponsors
  • 8.
    Not possible to specify2 trials
    231 other sponsors
  • 9.
    Anesthesia and Analgesia1 trial
    101 other sponsors
  • 10.
    Cardiovascular Diseases1 trial
    375 other sponsors
  • 11.
    Digestive System Diseases1 trial
    284 other sponsors
  • 12.
    Eye Diseases1 trial
    145 other sponsors
  • 13.
    Female Urogenital Diseases and Pregnancy Complications1 trial
    150 other sponsors
  • 14.
    Hormonal diseases1 trial
    94 other sponsors
  • 15.
    Pathological Conditions, Signs and Symptoms1 trial
    91 other sponsors
  • 16.
    Skin and Connective Tissue Diseases1 trial
    257 other sponsors
  • 17.
    Surgical Procedures, Operative1 trial
    55 other sponsors
  • 18.
    Virus Diseases1 trial
    183 other sponsors

Partnered Research Centres

47 centres
location_city
assignment1
Ahvenanmaan keskussairaala
Address
Doktorsvägen 1, 22111 Mariehamn
Learn morearrow_forward
location_city
assignment17
Central Finland Hospital District Central Finland Hospital Nova
Address
Hoitajantie 3, 40620 Jyväskylä
Learn morearrow_forward
location_city
assignment6
Etela-Pohjanmaan Sairaanhoitopiiri
Address
Hanneksenrinne 7, 60220 Seinäjoki
Learn morearrow_forward
location_city
assignment3
Etelae-Karjalan hyvinvointialue
Address
Valto Kakelan Katu 3, 53130 Lappeenranta
Learn morearrow_forward
location_city
assignment2
Etelae-Savon hyvinvointialue
Address
Porrassalmenkatu 35-37, 50100 Mikkeli
Learn morearrow_forward
location_city
assignment12
Helse Forde HF
Address
Svanehaugvegen 2, 6812 Foerde
Learn morearrow_forward
Page 1 of 8

Want to get in touch with this sponsor?

Send a question and we'll pass it on to HUS-yhtymae.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.